A model of controlled acute hyperglycemia in rats: effects of insulin and glucagon-like peptide-1 analog

Journal of Pharmacology and Experimental Therapeutics

Volumn 316, Issue 3, 2006, Pages 1159-1164

  Saha, Joy K ^a   Xia, Jinqi ^a   Engle, Steven K ^a   Chen, Yun Fei ^a   Glaesner, Wolfgang ^a   Jakubowski, Joseph A ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUCOSE; GROWTH HORMONE; HUMAN INSULIN; INSULIN; KETAMINE; XYLAZINE;

ACUTE DISEASE; ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; GLUCAGON BLOOD LEVEL; GLUCOSE INFUSION; GROWTH HORMONE BLOOD LEVEL; HORMONE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; JUGULAR VEIN; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACUTE DISEASE; ANESTHESIA; ANIMALS; DISEASE MODELS, ANIMAL; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; GROWTH HORMONE; HYPERGLYCEMIA; INSULIN; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33644749357     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.093534     Document Type: Article

References (25)

1. Bergman SA (1999) Ketamine: review of its pharmacology and its use in pediatric anesthesia. Anesth Prog 46:10-20.
2. Black PR, Brooks DC, Bessey PQ, Wolfe RR, and Wilmore DW (1982) Mechanisms of insulin resistance following injury. Ann Surg 196:420-435.
3. Brandi LS, Santoro D, Natali A, Altomonte F, Baldi S, Frascerra S, and Ferrannini E (1993) Insulin resistance of stress: sites and mechanisms. Clin Sci 85:525-535.
4. Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, Lyden PD, Broderick JP, Kwiatkowski TG, and Fineberg SE (2002) NINDS rt-PA Stroke Study Group: admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 59:669-674.
5. Capes SE, Hunt D, Malmberg K, and Gerstein HC (2000) Stress hyperglycemia and increased risk after myocardial infarction in patients without diabetes: a systematic overview. Lancet 355:773-778.
6. Chernow B, Alexander HR, Smallridge RC, Thompson WR, Cook D, Beardsley D, Fink MP, Lake CR, and Fletcher JR (1987) Hormonal responses to graded surgical stress. Arch Intern Med 147:1273-1278.
7. Goldfine ID and Arieff AI (1979) Rapid inhibition of basal and glucose stimulated insulin release by xylazine. Endocrinology 105:920-930.
8. Greene SA (1999) Pros and cons of using alpha-2 agonists in small animal anesthesia practice. Clin Tech Small Anim Pract 14:10-14.
9. Hirsch IB (2002) In-patient hyperglycemia: are we ready to treat it yet? J Clin Endocrinol Metab 87:975-977.
10. Kawai N, Keep RF, and Betz AL (1997) Hyperglycemia and the vascular effects of cerebral ischemia. Stroke 28:149-154.
11. Kjems LL, Holst JJ, Volund A, and Madsbad S (2003) The influence of GLP-1 on glucose-stimulated insulin secretion. Diabetes 52:380-386.
12. Ling PR, Mueller C, Smith RJ, and Bistrian BR (2003) Hyperglycemia induced by glucose infusion causes hepatic oxidative stress and systemic inflammation, but not STAT 3 or MAP kinase activation in liver in rats. Metabolism 52:868-874.
13. Marfella R, D'Amico M, Di Filippo C, Piegari E, Nappo F, Esposito K, Berrino L, Rossi F, and Giugliano D (2002) Myocardial infarction in diabetic rats: role of hyperglycemia on infarct size and early expression of hypoxia-inducible factor. Diabetologia 45:1172-1181.
14. Nauck MA, Walberg J, Vethacke A, El-Quaghlidi A, Senkal M, Holst JJ, Gallwitz JB, Schmidt WE, and Schmiegel W (2004) Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide-1. Regul Pept 118:89-97.
15. Page T and Bailey CJ (1997) Glucose-lowering effect of BTS 67 582. Br J Pharmacol 122:1464-1468.
16. Saha JK, Xia J, Engle SK, and Jakubowski JA (2005a) Controlled induction of acute hyperglycemia in anesthetized rodents. FASEB J 19:A97.
17. Saha JK, Xia J, Grondin JM, Engle SK, and Jakubowski JA (2005b) Acute hyperglycemia induced by ketamine/xylazine anesthesia in rats: mechanisms and implications for pre-clinical models. Exp Biol Med 230:777-784.
18. Shiomi T, Tsutsui H, Ikeuchi M, Matsusaka H, Hayashidani S, Suematsu N, Wen J, and Kubota T (2003) Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction. J Am Coll Cardiol 42:165-172.
19. Symonds HW and Mallinson CB (1978) The effect of xylazine and xylazine followed by insulin on blood glucose and insulin in the dairy cow. Vet Rec 102:27-29.
20. Takahashi T, Matsuda K, Kono T, and Pappas TN (2003) Inhibitory effects of hyperglycemia on neural activity of the vagus in rats. Intensive Care Med 29:309-311.
21. Thorell A, Efendic S, Gutniak M, Haggmark T, and Liunggvist O (1993) Development of postoperative insulin resistance is associated with the magnitude of operation. Eur J Surg 159:593-599.
22. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers, and Bouillon R (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359-1367.
23. Villafana S, Huang F, and Hong E (2004) Role of the sympathetic and rennin angiotensin systems in the glucose-induced increase of blood pressure in rats. Eur J Pharmacol 506:143-150.
24. Vilsboll T, Krarup T, Madsbad S, and Holst JJ (2003) Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects. Regul Pept 114:115-121.
25. Wright M (1982) Pharmacologic effects of ketamine and its use in veterinary medicine. J Am Vet Med Assoc 180:1462-1471.